|
|||||
|
|
Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy |
|
| Affiliation: | 2. Thoracic Oncology Program, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan;3. Biostatistics Unit, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan |
| Abstract: | |
| Keywords: | Non-small cell lung cancer COX-2 Relapsed Docetaxel Celecoxib |
| 本文献已被 ScienceDirect 等数据库收录！ | |